BACKGROUND: Loss of imprinting (LOI) is an epigenetic alteration involving loss of parental origin-specific expression at normally imprinted genes. A LOI for IGF2, a paracrine growth factor, has been implicated in the development of prostate and other cancers. In the current study, we define IGF2 LOI in histologically normal prostate tissues in relationship to tumor foci and gene expression. METHODS: Microdissected tumor associated (TA) adjacent (2 mm) and distant (10 mm) tissues surrounding tumor foci were generated. IGF2 imprinting in informative prostate tissue sets was quantitated using a fluorescent primer extension assay and expression analyzed utilizing quantitative PCR. DNA methylation analyses were performed using quantitative pyrosequencing. RESULTS: A marked IGF2 LOI was found in adjacent TA tissues (39 ± 3.1%) and did not significantly decrease in tissues distant (38 ± 5.3%) from tumor foci (45 ± 2.9%; P = 0.21). IGF2 imprinting correlated with IGF2 expression in TA tissues, but not within the tumor foci. Hypomethylation of the IGF2 DMR0 region correlated with decreased IGF2 expression in tumors (P < 0.01). The expression of IGF2 and its adjacent imprinted gene H19 were increased in adjacent and distant tissues compared to tumors (P < 0.05) indicating the importance of factors other than LOI in driving IGF2 expression. CONCLUSIONS: LOI of IGF2 occurs not only adjacent to prostate tumor foci, but is widely prevalent even in distant areas within the peripheral zone. These data provide evidence for a widespread epigenetic field defect in histologically normal tissues that might be employed to identify prostate cancer in patients.
BACKGROUND: Loss of imprinting (LOI) is an epigenetic alteration involving loss of parental origin-specific expression at normally imprinted genes. A LOI for IGF2, a paracrine growth factor, has been implicated in the development of prostate and other cancers. In the current study, we define IGF2 LOI in histologically normal prostate tissues in relationship to tumor foci and gene expression. METHODS: Microdissected tumor associated (TA) adjacent (2 mm) and distant (10 mm) tissues surrounding tumor foci were generated. IGF2 imprinting in informative prostate tissue sets was quantitated using a fluorescent primer extension assay and expression analyzed utilizing quantitative PCR. DNA methylation analyses were performed using quantitative pyrosequencing. RESULTS: A marked IGF2 LOI was found in adjacent TA tissues (39 ± 3.1%) and did not significantly decrease in tissues distant (38 ± 5.3%) from tumor foci (45 ± 2.9%; P = 0.21). IGF2 imprinting correlated with IGF2 expression in TA tissues, but not within the tumor foci. Hypomethylation of the IGF2DMR0 region correlated with decreased IGF2 expression in tumors (P < 0.01). The expression of IGF2 and its adjacent imprinted gene H19 were increased in adjacent and distant tissues compared to tumors (P < 0.05) indicating the importance of factors other than LOI in driving IGF2 expression. CONCLUSIONS: LOI of IGF2 occurs not only adjacent to prostate tumor foci, but is widely prevalent even in distant areas within the peripheral zone. These data provide evidence for a widespread epigenetic field defect in histologically normal tissues that might be employed to identify prostate cancer in patients.
Authors: S L Li; H Goko; Z D Xu; G Kimura; Y Sun; M H Kawachi; T G Wilson; S Wilczynski; Y Fujita-Yamaguchi Journal: Cell Tissue Res Date: 1998-03 Impact factor: 5.249
Authors: C E Rogler; D Yang; L Rossetti; J Donohoe; E Alt; C J Chang; R Rosenfeld; K Neely; R Hintz Journal: J Biol Chem Date: 1994-05-13 Impact factor: 5.157
Authors: Matthew Truong; Bing Yang; Andrew Livermore; Jennifer Wagner; Puspha Weeratunga; Wei Huang; Rajiv Dhir; Joel Nelson; Daniel W Lin; David F Jarrard Journal: J Urol Date: 2012-11-15 Impact factor: 7.450
Authors: Teodora Ribarska; Wolfgang Goering; Johanna Droop; Klaus-Marius Bastian; Marc Ingenwerth; Wolfgang A Schulz Journal: Epigenetics Date: 2014-02-10 Impact factor: 4.528
Authors: Yin Cao; Sara Lindström; Fredrick Schumacher; Victoria L Stevens; Demetrius Albanes; Sonja Berndt; Heiner Boeing; H Bas Bueno-de-Mesquita; Federico Canzian; Saioa Chamosa; Stephen J Chanock; W Ryan Diver; Susan M Gapstur; J Michael Gaziano; Edward L Giovannucci; Christopher A Haiman; Brian Henderson; Mattias Johansson; Loïc Le Marchand; Domenico Palli; Bernard Rosner; Afshan Siddiq; Meir Stampfer; Daniel O Stram; Rulla Tamimi; Ruth C Travis; Dimitrios Trichopoulos; Walter C Willett; Meredith Yeager; Peter Kraft; Ann W Hsing; Michael Pollak; Xihong Lin; Jing Ma Journal: J Natl Cancer Inst Date: 2014-06 Impact factor: 13.506